Thomas W. Burnell - 21 May 2021 Form 4 Insider Report for INTERPACE BIOSCIENCES, INC. (IDXG)

Role: President & CEO, Director
Signature: By: /s/ Thomas W. Burnell
Issuer symbol: IDXG
Transactions as of: 21 May 2021
Net transactions value: +$94,221
Form type: 4
Filing time: 25 May 2021, 17:25:24 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IDXG	Common Stock	Purchase	$94,221	+10,855		$8.68^*	10,855	21 May 2021	By: Spouse	F1, F2
holding	IDXG	Restricted Stock Units						225,000	21 May 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.17 to $8.80. The Reporting Person undertakes to provide Interpace Biosciences, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	- These shares are owned by Mr. Burnell's spouse. Mr. Burnell disclaims beneficial ownership of these shares.

Content

- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.17 to $8.80. The Reporting Person undertakes to provide Interpace Biosciences, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

- These shares are owned by Mr. Burnell's spouse. Mr. Burnell disclaims beneficial ownership of these shares.